Literature DB >> 19712005

UGT1A1, UGT1A6 and UGT1A7 genetic analysis: repercussion for irinotecan pharmacogenetics in the São Miguel Island Population (Azores, Portugal).

Paula R Pacheco1, Maria J Brilhante, Cristina Ballart, Francesc Sigalat, Helena Polena, Rita Cabral, Claudia C Branco, Luisa Mota-Vieira.   

Abstract

BACKGROUND: Glucuronidation reactions, catalyzed by uridine-diphosphate glucuronosyltransferase (UGT) enzymes, constitute a detoxification process that adds glucuronic acid to endogenous and exogenous compounds, aiding their excretion. UGT1A proteins have been implicated as risk factors for both the development of cancer and adverse drug effects.
METHODS: Here, we assess the genome of 469 individuals from São Miguel Island (Azores, Portugal) in order to determine the frequencies of polymorphisms and haplotypes in UGT1A1, UGT1A6, and UGT1A7, the co-occurrence of reduced enzyme activity UGT1A variants related to irinotecan toxicity, and to calculate the extent of linkage disequilibrium (LD) in the genomic region encompassing these genes.
RESULTS: Allelic analysis disclosed the presence of rare alleles - UGT1A1*36 and UGT1A1*37--only found in individuals of African descent, and UGT1A7*4. These alleles confirm our previous results on the São Miguel Island genetic background. We identified five different genotypes in UGT1A1 and UGT1A6 and nine in UGT1A7. Haplotype analysis showed that three haplotypes constituted approximately 80% of the allelic variants. Interestingly, haplotype 3 (UGT1A1*28-UGT1A6*2-UGT1A7*3), with a frequency of 0.235, gathers the three alleles encoding the low-function UGT isoforms. Additionally, LD indicates a strong interaction between functional polymorphisms related to the alteration of the UGT enzyme activity.
CONCLUSIONS: In summary, the results demonstrate a high variability of alleles and haplotypes, which have important roles in modifying expression and activity of UGTs. The data presented here could improve the understanding of the predisposition to cancers and susceptibility to the adverse effects of irinotecan in the São Miguel Island population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712005     DOI: 10.2165/11317170-000000000-00000

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  36 in total

Review 1.  "Irinogenetics" and UGT1A: from genotypes to haplotypes.

Authors:  Federico Innocenti; Mark J Ratain
Journal:  Clin Pharmacol Ther       Date:  2004-06       Impact factor: 6.875

2.  The Y-chromosomal heritage of the Azores Islands population.

Authors:  P R Pacheco; C C Branco; R Cabral; S Costa; A L Araújo; B R Peixoto; P Mendonça; L Mota-Vieira
Journal:  Ann Hum Genet       Date:  2005-03       Impact factor: 1.670

3.  Azores Islands: genetic origin, gene flow and diversity pattern.

Authors:  Claudia C Branco; Marta São Bento; Cidália T Gomes; Rita Cabral; Paula R Pacheco; Luisa Mota-Vieira
Journal:  Ann Hum Biol       Date:  2008 Jan-Feb       Impact factor: 1.533

4.  UDP-glucuronosyltransferase activity in human liver and colon.

Authors:  C P Strassburg; N Nguyen; M P Manns; R H Tukey
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

5.  UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females.

Authors:  J Mercke Odeberg; J Andrade; K Holmberg; P Hoglund; U Malmqvist; J Odeberg
Journal:  Eur J Clin Pharmacol       Date:  2006-08-15       Impact factor: 2.953

6.  Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer.

Authors:  C P Strassburg; A Vogel; S Kneip; R H Tukey; M P Manns
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

7.  Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity.

Authors:  Moshe Finel; Xin Li; Dione Gardner-Stephen; Stacie Bratton; Peter I Mackenzie; Anna Radominska-Pandya
Journal:  J Pharmacol Exp Ther       Date:  2005-08-24       Impact factor: 4.030

Review 8.  Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.

Authors:  A Kadakol; S S Ghosh; B S Sappal; G Sharma; J R Chowdhury; N R Chowdhury
Journal:  Hum Mutat       Date:  2000-10       Impact factor: 4.878

9.  Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells.

Authors:  Swati Nagar; Jeffrey J Zalatoris; Rebecca L Blanchard
Journal:  Pharmacogenetics       Date:  2004-08

10.  Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Authors:  E Beutler; T Gelbart; A Demina
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more
  5 in total

1.  Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Dhandapani Kayathiri; Subramanian Rajan; Deepak Gopal Shewade; Steven Aibor Dkhar; Sajjanavar Manjunath; Prayaga Ushakiran; Gangadharan Reneega; Kukreti Ritushree; Chandrasekaran Adithan
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

Review 2.  Uridine 5'-diphospho-glucronosyltrasferase: Its role in pharmacogenomics and human disease.

Authors:  Celia N Sanchez-Dominguez; Hugo L Gallardo-Blanco; Mauricio A Salinas-Santander; Rocio Ortiz-Lopez
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

3.  UGT1A1 is a major locus influencing bilirubin levels in African Americans.

Authors:  Guanjie Chen; Edward Ramos; Adebowale Adeyemo; Daniel Shriner; Jie Zhou; Ayo P Doumatey; Hanxia Huang; Michael R Erdos; Norman P Gerry; Alan Herbert; Amy R Bentley; Huichun Xu; Bashira A Charles; Michael F Christman; Charles N Rotimi
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

4.  Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations.

Authors:  Hiromichi Maeda; Shoichi Hazama; Abdiev Shavkat; Ken Okamoto; Koji Oba; Junichi Sakamoto; Kenichi Takahashi; Masaki Oka; Daisuke Nakamura; Ryouichi Tsunedomi; Naoko Okayama; Hideyuki Mishima; Michiya Kobayashi
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

5.  UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population.

Authors:  Ley-Fang Kua; Soo Ross; Soo-Chin Lee; Kousaku Mimura; Koji Kono; Boon-Cher Goh; Wei-Peng Yong
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.